Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial

              Author:Goadsby, Peter J.   Ailani, Jessica   Dodick, David W.   J. Starling, Amaal   Liu, Chengcheng   Yu, Sung Yun   Brand-Schieber, Elimor   Finnegan, Michelle   M. Trugman, Joel   

              Session Name:S47: Advances in Migraine Therapeutics  

              Topic:Headache  

              Program Number:S47.002  

              Author Institution:King's College and University of California Los Angeles, London, United Kingdom  Medstar Georgetown Neurology, McLean, VA  Mayo Clinic, Phoenix, AZ  AbbVie, Madison, NJ  

              Rimegepant for the Acute and Preventive Treatment of Migraine in Women: Results From 4 Randomized, Placebo-Controlled Clinical Trials

              Author:Hutchinson, Susan   Pavlovic, Jelena   Ailani, Jessica   Mullin, Kathleen   Croop, Robert   Thiry, Alexandra   Morris, Beth   Kamen, Lisa   Abbott, Chandra   

              Session Name:P9: Headache: The Gepant Pipeline  

              Topic:Headache  

              Program Number:P9.007  

              Author Institution:Orange County Migraine & Headache Center, Irvine, CA  Albert Einstein College of Medicine, Bronx, NY  Medstar Georgetown Neurology, McLean, VA  New England Institute for Neurology and Headache, Stamford, CT  Biohaven Pharmaceuticals, Wynnewood, PA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Inc., New Haven, CT  

              Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study

              Author:Croop, Robert   Ailani, Jessica   Kudrow, David   Smith, Timothy   Lipton, Richard   Thiry, Alexandra   Jensen, Christopher   Kamen, Lisa   

              Session Name:P10: Headache: Towards Precision Medicine 1  

              Topic:Headache  

              Program Number:P10.010  

              Author Institution:Biohaven Pharmaceuticals , Wynnewood, PA  Medstar Georgetown Neurology, McLean, VA  David Kudrow MD, Los Angeles, CA  Study Metrix Research, Saint Peters, MO  Albert Einstein College of Medicine, Bronx, NY  Biohaven Pharmaceuticals, New Haven, CT  

              Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis of the ADVANCE Trial

              Author:Nahas, Stephanie   Ailani, Jessica   McAllister, Peter   Halker Singh, Rashmi   Lipton, Richard B.   Ma, Julia   Gandhi, Pranav   Smith, Jonathan H.   Liu, Yingyi   Chalermpalanupap, Natty   Dabruzzo, Brett   

              Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

              Topic:Headache  

              Program Number:P12.001  

              Author Institution:Thomas Jefferson University, Philadelphia, PA  Medstar Georgetown Neurology, McLean, VA  New England Inst for Neurology and Headache, Stamford, CT  Mayo Clinic, Scottsdale, AZ  Albert Einstein College of Medicine, Bronx, NY  AbbVie, Madison, NJ  AbbVie, North Chicago, IL  AbbVie , Frederick, MD  

              Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase

              Author:Lipton, Richard   Kudrow, David   Smith, Timothy   Ailani, Jessica   Goadsby, Peter   Kamen, Lisa   Thiry, Alexandra   Jensen, Christopher   Croop, Robert   

              Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

              Topic:Headache  

              Program Number:P12.006  

              Author Institution:Albert Einstein College of Medicine, Bronx, NY  David Kudrow MD, Los Angeles, CA  StudyMetrix Research, Saint Louis, MO  Medstar Georgetown Neurology, McLean, VA  University of California, Los Angeles, Los Angeles, CA  Biohaven Pharmaceuticals, Inc., New Haven, CT  Biohaven Pharmaceuticals, New Haven, CT